Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Nov, 2019 | Pages:
119 | Publisher: XYZResearch
Industry: Medical Devices | Report Format: Electronic (PDF)
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Oral Vaccines in these regions, from 2012 to 2023 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Oral Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
GlaxoSmithKline Plc.
PaxVax Corporation
Pfizer Inc
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUiMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oral Vaccines for each application, including
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Oral Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2025
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Oral Vaccines Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Product Type Market
2.1 World Product Type Market Performance and Trend
2.1.1 World Market Performance
2.1.2 Different Type of Market Performance
2.2 North America Product Type Market Performance and Trend
2.2.1 North America Market Performance
2.2.2 Different Type of Market Performance
2.3 Europe Product Type Market Performance and Trend
2.3.1 Europe Market Performance
2.3.2 Different Type of Market Performance
2.4 Asia-Pacific Product Type Market Performance and Trend
2.4.1 Asia-Pacific Market Performance
2.4.2 Different Type of Market Performance
2.5 South America Product Type Market Performance and Trend
2.5.1 South America Market Performance
2.5.2 Different Type of Market Performance
2.6 Middle East and Africa Product Type Market Performance and Trend
2.6.1 Middle East and Africa Market Performance
2.6.2 Different Type of Market Performance
3 Product Application Market
3.1 World Product Application Market Performance and Trend
3.1.1 World Market Performance
3.1.2 Different Applications of Market Trend
3.2 North America Product Application Market Performance and Trend
3.2.1 North America Market Performance
3.2.2 Different Applications of Market Trend
3.3 Europe Product Application Market Performance and Trend
3.3.1 Europe Market Performance
3.3.2 Different Applications of Market Trend
3.4 Asia-Pacific Product Application Market Performance and Trend
3.4.1 Asia-Pacific Market Performance
3.4.2 Different Applications of Market Trend
3.5 South America Product Application Market Performance and Trend
3.5.1 South America Market Performance
3.5.2 Different Applications of Market Trend
3.6 Middle East and Africa Product Application Market Performance and Trend
3.6.1 Middle East and Africa Market Performance
3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
4.1 GlaxoSmithKline Plc.
4.1.1 GlaxoSmithKline Plc. Profiles
4.1.2 GlaxoSmithKline Plc. Product Information
4.1.3 GlaxoSmithKline Plc. Oral Vaccines Business Performance
4.1.4 GlaxoSmithKline Plc. Oral Vaccines Business Development and Market Status
4.2 PaxVax Corporation
4.2.1 PaxVax Corporation Profiles
4.2.2 PaxVax Corporation Product Information
4.2.3 PaxVax Corporation Oral Vaccines Business Performance
4.2.4 PaxVax Corporation Oral Vaccines Business Development and Market Status
4.3 Pfizer Inc
4.3.1 Pfizer Inc Profiles
4.3.2 Pfizer Inc Product Information
4.3.3 Pfizer Inc Oral Vaccines Business Performance
4.3.4 Pfizer Inc Oral Vaccines Business Development and Market Status
4.4 Merial, Inc.
4.4.1 Merial, Inc. Profiles
4.4.2 Merial, Inc. Product Information
4.4.3 Merial, Inc. Oral Vaccines Business Performance
4.4.4 Merial, Inc. Oral Vaccines Business Development and Market Status
4.5 Merck Sharp & Dohme Corp
4.5.1 Merck Sharp & Dohme Corp Profiles
4.5.2 Merck Sharp & Dohme Corp Product Information
4.5.3 Merck Sharp & Dohme Corp Oral Vaccines Business Performance
4.5.4 Merck Sharp & Dohme Corp Oral Vaccines Business Development and Market Status
4.6 VALNEVA Canada Inc.
4.6.1 VALNEVA Canada Inc. Profiles
4.6.2 VALNEVA Canada Inc. Product Information
4.6.3 VALNEVA Canada Inc. Oral Vaccines Business Performance
4.6.4 VALNEVA Canada Inc. Oral Vaccines Business Development and Market Status
4.7 QUiMICA SUIZA S.A
4.7.1 QUiMICA SUIZA S.A Profiles
4.7.2 QUiMICA SUIZA S.A Product Information
4.7.3 QUiMICA SUIZA S.A Oral Vaccines Business Performance
4.7.4 QUiMICA SUIZA S.A Oral Vaccines Business Development and Market Status
4.8 Immunitor, Inc
4.8.1 Immunitor, Inc Profiles
4.8.2 Immunitor, Inc Product Information
4.8.3 Immunitor, Inc Oral Vaccines Business Performance
4.8.4 Immunitor, Inc Oral Vaccines Business Development and Market Status
4.9 Aventis (Sanofi S.A.)
4.9.1 Aventis (Sanofi S.A.) Profiles
4.9.2 Aventis (Sanofi S.A.) Product Information
4.9.3 Aventis (Sanofi S.A.) Oral Vaccines Business Performance
4.9.4 Aventis (Sanofi S.A.) Oral Vaccines Business Development and Market Status
4.10 Serum Institute of India Pvt. Ltd
4.10.1 Serum Institute of India Pvt. Ltd Profiles
4.10.2 Serum Institute of India Pvt. Ltd Product Information
4.10.3 Serum Institute of India Pvt. Ltd Oral Vaccines Business Performance
4.10.4 Serum Institute of India Pvt. Ltd Oral Vaccines Business Development and Market Status
4.11 Swiss Serum and Vaccine Institute Berne
4.12 Bull Bio - NCIPD Ltd.
4.13 Vaxart, Inc.
4.14 Shantha Biotechnics
4.15 Crucell (Janssen Global Services, LLC)
5 Market Performance for Manufacturers
5.1 Global Oral Vaccines Sales (K Units) and Market Share by Manufacturers 2014-2019
5.2 Global Oral Vaccines Revenue (M USD) and Market Share by Manufacturers 2014-2019
5.3 Global Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
5.4 Global Oral Vaccines Gross Margin of Manufacturers 2014-2019
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 North America Market Performance for Manufacturers
6.1.1 North America Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
6.1.2 North America Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
6.1.3 North America Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
6.1.4 North America Oral Vaccines Gross Margin of Manufacturers 2014-2019
6.1.5 Market Concentration
6.2 Europe Market Performance for Manufacturers
6.2.1 Europe Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
6.2.2 Europe Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
6.2.3 Europe Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
6.2.4 Europe Oral Vaccines Gross Margin of Manufacturers 2014-2019
6.2.5 Market Concentration
6.3 Asia-Pacific Market Performance for Manufacturers
6.3.1 Asia-Pacific Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
6.3.2 Asia-Pacific Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
6.3.3 Asia-Pacific Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
6.3.4 Asia-Pacific Oral Vaccines Gross Margin of Manufacturers 2014-2019
6.3.5 Market Concentration
6.4 South America Market Performance for Manufacturers
6.4.1 South America Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
6.4.2 South America Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
6.4.3 South America Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
6.4.4 South America Oral Vaccines Gross Margin of Manufacturers 2014-2019
6.4.5 Market Concentration
6.5 Middle East and Africa Market Performance for Manufacturers
6.5.1 Middle East and Africa Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
6.5.2 Middle East and Africa Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
6.5.3 Middle East and Africa Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
6.5.4 Middle East and Africa Oral Vaccines Gross Margin of Manufacturers 2014-2019
6.5.5 Market Concentration
7 World Market Performance Point
7.1 World Oral Vaccines Sales (K Units) and Share by Regions and Countries 2014-2019
7.1.1 World Oral Vaccines Sales (K Units) and Share by Regions 2014-2019
7.1.2 Regional Sales (K Units) and Share by Countries 2014-2019
7.1.2.1 Asia-Pacific Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
7.1.2.2 North America Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
7.1.2.3 Europe Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
7.1.2.4 South America Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
7.1.2.5 Middle East and Africa Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
7.2 World Revenue (M USD) and Share by Regions and Countries 2014-2019
7.2.1 World Revenue (M USD) and Share by Regions 2014-2019
7.2.2 Regional Revenue (M USD) and Share by Countries 2014-2019
7.2.2.1 Asia-Pacific Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
7.2.2.2 North America Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
7.2.2.3 Europe Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
7.2.2.4 South America Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
7.2.2.5 Middle East and Africa Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
7.3 World Price (USD/Unit) by Regions and Countries 2014-2019
7.3.1 World Price (USD/Unit) by Regions 2014-2019
7.3.2 Regional Price (USD/Unit) by Countries 2014-2019
7.3.2.1 Asia-Pacific Oral Vaccines Price (USD/Unit) by Countries 2014-2019
7.3.2.2 North America Oral Vaccines Price (USD/Unit) by Countries 2014-2019
7.3.2.3 Europe Oral Vaccines Price (USD/Unit) by Countries 2014-2019
7.3.2.4 South America Oral Vaccines Price (USD/Unit) by Countries 2014-2019
7.3.2.5 Middle East and Africa Oral Vaccines Price (USD/Unit) by Countries 2014-2019
7.4 World Gross Margin by Regions and Countries 2014-2019
7.4.1 World Gross Margin by Regions 2014-2019
7.4.2 Regional Gross Margin and Share by Countries 2014-2019
7.4.2.1 Asia-Pacific Oral Vaccines Gross Margin and Share by Countries 2014-2019
7.4.2.2 North America Oral Vaccines Gross Margin and Share by Countries 2014-2019
7.4.2.3 Europe Oral Vaccines Gross Margin and Share by Countries 2014-2019
7.4.2.4 South America Oral Vaccines Gross Margin and Share by Countries 2014-2019
7.4.2.5 Middle East and Africa Oral Vaccines Gross Margin and Share by Countries 2014-2019
8 Development Trend for Regions and Countries (Sales Point)
8.1 World Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3 North America Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4 Europe Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5 South America Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6 Middle East and Africa Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Polio Industry
11.2 Rabies Industry
11.3 Rotavirus Industry
11.4 Cholera Industry
11.5 HIV Industry
11.6 Respiratory Infections Industry
11.7 Influenza Industry
11.8 Tuberculosis Industry
11.9 Others Industry
12 Market Forecast 2020-2025
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
12.1.1 Global Oral Vaccines Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
12.1.2 Global Oral Vaccines Sales (K Units) and Growth Rate 2020-2025
12.1.3 Asia-Pacific Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.4 North America Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.5 Europe Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.6 South America Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.1.7 Middle East and Africa Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2 World Oral Vaccines Sales (K Units) and Revenue (M USD) Forecast by Types 2020-2025
12.2.1 Overall Market Performance
12.2.2 Live Attenuated Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2.3 Killed/Inactivated Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2.4 Recombinant Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
12.3 World Oral Vaccines Market Forecast by Application 2020-2025
12.3.1 Overall Market Performance
12.3.2 Polio Sales and and Growth Rate 2020-2025
12.3.3 Rabies Sales and and Growth Rate 2020-2025
12.3.4 Rotavirus Sales and and Growth Rate 2020-2025
12.3.5 Cholera Sales and and Growth Rate 2020-2025
12.3.6 HIV Sales and and Growth Rate 2020-2025
12.3.7 Respiratory Infections Sales and and Growth Rate 2020-2025
12.3.8 Influenza Sales and and Growth Rate 2020-2025
12.3.9 Tuberculosis Sales and and Growth Rate 2020-2025
12.3.10 Others Sales and and Growth Rate 2020-2025
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Global Oral Vaccines Price (USD/Unit) Trend 2020-2025
12.4.2 Global Oral Vaccines Gross Profit Trend 2020-2025
13 Conclusion
List of Tables and Figures Figure Product Picture of Oral Vaccines Table Product Specifications of Oral Vaccines Table Manufacturers List in the Report Table Manufacturers Market Share 2014-2019 Table Regions Overview in the Report Table Product Type and Standard Table Type Overview Table Product Application and Standard Table Application Overview in the Report Figure Industry Chain Structure of Oral Vaccines Table Industry News List of Oral Vaccines Figure New Project SWOT Analysis of Oral Vaccines Table World 2014-2019 Oral Vaccines Sales (K Units) by Type Figure World Oral Vaccines Sales Market Share (%) by Type in 2014 Figure World Oral Vaccines Sales Market Share (%) by Type in 2019 Table World 2014-2019 Oral VaccinesRevenue (M USD) by Type Figure World Oral VaccinesRevenue Market Share (%) by Type in 2014 Figure World Oral VaccinesRevenue Market Share (%) by Type in 2019 Table World Live Attenuated Vaccines Sales (K Units) and Growth Rate Figure World Live Attenuated Vaccines Sales (K Units) and Growth Rate Table World Live Attenuated Vaccines Revenue (M USD) and Growth Rate Figure World Live Attenuated Vaccines Revenue (M USD) and Growth Rate Table World Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Figure World Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Table World Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Figure World Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Table World Recombinant Vaccines Sales (K Units) and Growth Rate Figure World Recombinant Vaccines Sales (K Units) and Growth Rate Table World Recombinant Vaccines Revenue (M USD) and Growth Rate Figure World Recombinant Vaccines Revenue (M USD) and Growth Rate Table World Others Sales (K Units) and Growth Rate Figure World Others Sales (K Units) and Growth Rate Table World Others Revenue (M USD) and Growth Rate Figure World Others Revenue (M USD) and Growth Rate Table North America 2014-2019 Oral Vaccines Sales (K Units) by Type Figure North America Oral Vaccines Sales Market Share (%) by Type in 2014 Figure North America Oral Vaccines Sales Market Share (%) by Type in 2019 Table North America 2014-2019 Oral VaccinesRevenue (M USD) by Type Figure North America Oral Vaccines Revenue Market Share (%) by Type in 2014 Figure North America Oral Vaccines Revenue Market Share (%) by Type in 2019 Table North America Live Attenuated Vaccines Sales (K Units) and Growth Rate Figure North America Live Attenuated Vaccines Sales (K Units) and Growth Rate Table North America Live Attenuated Vaccines Revenue (M USD) and Growth Rate Figure North America Live Attenuated Vaccines Revenue (M USD) and Growth Rate Table North America Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Figure North America Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Table North America Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Figure North America Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Table North America Recombinant Vaccines Sales (K Units) and Growth Rate Figure North America Recombinant Vaccines Sales (K Units) and Growth Rate Table North America Recombinant Vaccines Revenue (M USD) and Growth Rate Figure North America Recombinant Vaccines Revenue (M USD) and Growth Rate Table North America Others Sales (K Units) and Growth Rate Figure North America Others Sales (K Units) and Growth Rate Table North America Others Revenue (M USD) and Growth Rate Figure North America Others Revenue (M USD) and Growth Rate Table Europe 2014-2019 Oral Vaccines Sales (K Units) by Type Figure Europe Oral Vaccines Sales Market Share (%) by Type in 2014 Figure Europe Oral Vaccines Sales Market Share (%) by Type in 2019 Table Europe 2014-2019 Oral VaccinesRevenue (M USD) by Type Figure Europe Oral VaccinesRevenue Market Share (%) by Type in 2014 Figure Europe Oral VaccinesRevenue Market Share (%) by Type in 2019 Table Europe Live Attenuated Vaccines Sales (K Units) and Growth Rate Figure Europe Live Attenuated Vaccines Sales (K Units) and Growth Rate Table Europe Live Attenuated Vaccines Revenue (M USD) and Growth Rate Figure Europe Live Attenuated Vaccines Revenue (M USD) and Growth Rate Table Europe Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Figure Europe Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Table Europe Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Figure Europe Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Table Europe Recombinant Vaccines Sales (K Units) and Growth Rate Figure Europe Recombinant Vaccines Sales (K Units) and Growth Rate Table Europe Recombinant Vaccines Revenue (M USD) and Growth Rate Figure Europe Recombinant Vaccines Revenue (M USD) and Growth Rate Table Europe Others Sales (K Units) and Growth Rate Figure Europe Others Sales (K Units) and Growth Rate Table Europe Others Revenue (M USD) and Growth Rate Figure Europe Others Revenue (M USD) and Growth Rate Table Asia-Pacific 2014-2019 Oral Vaccines Sales (K Units) by Type Figure Asia-Pacific Oral Vaccines Sales Market Share (%) by Type in 2014 Figure Asia-Pacific Oral Vaccines Sales Market Share (%) by Type in 2019 Table Asia-Pacific 2014-2019 Oral VaccinesRevenue (M USD) by Type Figure Asia-Pacific Oral VaccinesRevenue Market Share (%) by Type in 2014 Figure Asia-Pacific Oral VaccinesRevenue Market Share (%) by Type in 2019 Table Asia-Pacific Live Attenuated Vaccines Sales (K Units) and Growth Rate Figure Asia-Pacific Live Attenuated Vaccines Sales (K Units) and Growth Rate Table Asia-Pacific Live Attenuated Vaccines Revenue (M USD) and Growth Rate Figure Asia-Pacific Live Attenuated Vaccines Revenue (M USD) and Growth Rate Table Asia-Pacific Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Figure Asia-Pacific Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Table Asia-Pacific Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Figure Asia-Pacific Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Table Asia-Pacific Recombinant Vaccines Sales (K Units) and Growth Rate Figure Asia-Pacific Recombinant Vaccines Sales (K Units) and Growth Rate Table Asia-Pacific Recombinant Vaccines Revenue (M USD) and Growth Rate Figure Asia-Pacific Recombinant Vaccines Revenue (M USD) and Growth Rate Table Asia-Pacific Others Sales (K Units) and Growth Rate Figure Asia-Pacific Others Sales (K Units) and Growth Rate Table Asia-Pacific Others Revenue (M USD) and Growth Rate Figure Asia-Pacific Others Revenue (M USD) and Growth Rate Table South America 2014-2019 Oral Vaccines Sales (K Units) by Type Figure South America Oral Vaccines Sales Market Share (%) by Type in 2014 Figure South America Oral Vaccines Sales Market Share (%) by Type in 2019 Table South America 2014-2019 Oral VaccinesRevenue (M USD) by Type Figure South America Oral VaccinesRevenue Market Share (%) by Type in 2014 Figure South America Oral VaccinesRevenue Market Share (%) by Type in 2019 Table South America Live Attenuated Vaccines Sales (K Units) and Growth Rate Figure South America Live Attenuated Vaccines Sales (K Units) and Growth Rate Table South America Live Attenuated Vaccines Revenue (M USD) and Growth Rate Figure South America Live Attenuated Vaccines Revenue (M USD) and Growth Rate Table South America Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Figure South America Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Table South America Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Figure South America Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Table South America Recombinant Vaccines Sales (K Units) and Growth Rate Figure South America Recombinant Vaccines Sales (K Units) and Growth Rate Table South America Recombinant Vaccines Revenue (M USD) and Growth Rate Figure South America Recombinant Vaccines Revenue (M USD) and Growth Rate Table South America Others Sales (K Units) and Growth Rate Figure South America Others Sales (K Units) and Growth Rate Table South America Others Revenue (M USD) and Growth Rate Figure South America Others Revenue (M USD) and Growth Rate Table Middle East and Africa 2014-2019 Oral Vaccines Sales (K Units) by Type Figure Middle East and Africa Oral Vaccines Sales Market Share (%) by Type in 2014 Figure Middle East and Africa Oral Vaccines Sales Market Share (%) by Type in 2019 Table Middle East and Africa 2014-2019 Oral VaccinesRevenue (M USD) by Type Figure Middle East and Africa Oral VaccinesRevenue Market Share (%) by Type in 2014 Figure Middle East and Africa Oral VaccinesRevenue Market Share (%) by Type in 2019 Table Middle East and Africa Live Attenuated Vaccines Sales (K Units) and Growth Rate Figure Middle East and Africa Live Attenuated Vaccines Sales (K Units) and Growth Rate Table Middle East and Africa Live Attenuated Vaccines Revenue (M USD) and Growth Rate Figure Middle East and Africa Live Attenuated Vaccines Revenue (M USD) and Growth Rate Table Middle East and Africa Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Figure Middle East and Africa Killed/Inactivated Vaccines Sales (K Units) and Growth Rate Table Middle East and Africa Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Figure Middle East and Africa Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate Table Middle East and Africa Recombinant Vaccines Sales (K Units) and Growth Rate Figure Middle East and Africa Recombinant Vaccines Sales (K Units) and Growth Rate Table Middle East and Africa Recombinant Vaccines Revenue (M USD) and Growth Rate Figure Middle East and Africa Recombinant Vaccines Revenue (M USD) and Growth Rate Table Middle East and Africa Others Sales (K Units) and Growth Rate Figure Middle East and Africa Others Sales (K Units) and Growth Rate Table Middle East and Africa Others Revenue (M USD) and Growth Rate Figure Middle East and Africa Others Revenue (M USD) and Growth Rate Table World 2014-2019 Oral Vaccines Sales (K Units) by Application Figure World Oral Vaccines Sales Market Share (%) by Application in 2014 Figure World Oral Vaccines Sales Market Share (%) by Application in 2019 Table World Polio Sales (K Units) and Growth Rate Figure World Polio Sales (K Units) and Growth Rate Table World Rabies Sales (K Units) and Growth Rate Figure World Rabies Sales (K Units) and Growth Rate Table World Rotavirus Sales (K Units) and Growth Rate Figure World Rotavirus Sales (K Units) and Growth Rate Table World Cholera Sales (K Units) and Growth Rate Figure World Cholera Sales (K Units) and Growth Rate Table North America Oral Vaccines Sales (K Units) by Application 2014-2019 Figure North America Oral Vaccines Sales Market Share (%) by Application in 2014 Figure North America Oral Vaccines Sales Market Share (%) by Application in 2019 Table North America Polio Sales (K Units) and Growth Rate Figure North America Polio Sales (K Units) and Growth Rate Table North America Rabies Sales (K Units) and Growth Rate Figure North America Rabies Sales (K Units) and Growth Rate Table North America Rotavirus Sales (K Units) and Growth Rate Figure North America Rotavirus Sales (K Units) and Growth Rate Table North America Cholera Sales (K Units) and Growth Rate Figure North America Cholera Sales (K Units) and Growth Rate Table Europe 2014-2019 Oral Vaccines Sales (K Units) by Application Figure Europe Oral Vaccines Sales Market Share (%) by Application in 2014 Figure Europe Oral Vaccines Sales Market Share (%) by Application in 2019 Table Europe Polio Sales (K Units) and Growth Rate Figure Europe Polio Sales (K Units) and Growth Rate Table Europe Rabies Sales (K Units) and Growth Rate Figure Europe Rabies Sales (K Units) and Growth Rate Table Europe Rotavirus Sales (K Units) and Growth Rate Figure Europe Rotavirus Sales (K Units) and Growth Rate Table Europe Cholera Sales (K Units) and Growth Rate Figure Europe Cholera Sales (K Units) and Growth Rate Table Asia-Pacific 2014-2019 Oral Vaccines Sales (K Units) by Application Figure Asia-Pacific Oral Vaccines Sales Market Share (%) by Application in 2014 Figure Asia-Pacific Oral Vaccines Sales Market Share (%) by Application in 2019 Table Asia-Pacific Polio Sales (K Units) and Growth Rate Figure Asia-Pacific Polio Sales (K Units) and Growth Rate Table Asia-Pacific Rabies Sales (K Units) and Growth Rate Figure Asia-Pacific Rabies Sales (K Units) and Growth Rate Table Asia-Pacific Rotavirus Sales (K Units) and Growth Rate Figure Asia-Pacific Rotavirus Sales (K Units) and Growth Rate Table Asia-Pacific Cholera Sales (K Units) and Growth Rate Figure Asia-Pacific Cholera Sales (K Units) and Growth Rate Table South America 2014-2019 Oral Vaccines Sales (K Units) by Application Figure South America Oral Vaccines Sales Market Share (%) by Application in 2014 Figure South America Oral Vaccines Sales Market Share (%) by Application in 2019 Table South America Polio Sales (K Units) and Growth Rate Figure South America Polio Sales (K Units) and Growth Rate Table South America Rabies Sales (K Units) and Growth Rate Figure South America Rabies Sales (K Units) and Growth Rate Table South America Rotavirus Sales (K Units) and Growth Rate Figure South America Rotavirus Sales (K Units) and Growth Rate Table South America Cholera Sales (K Units) and Growth Rate Figure South America Cholera Sales (K Units) and Growth Rate Table Middle East and Africa 2014-2019 Oral Vaccines Sales (K Units) by Application Figure Middle East and Africa Oral Vaccines Sales Market Share (%) by Application in 2014 Figure Middle East and Africa Oral Vaccines Sales Market Share (%) by Application in 2019 Table Middle East and Africa Polio Sales (K Units) and Growth Rate Figure Middle East and Africa Polio Sales (K Units) and Growth Rate Table Middle East and Africa Rabies Sales (K Units) and Growth Rate Figure Middle East and Africa Rabies Sales (K Units) and Growth Rate Table Middle East and Africa Rotavirus Sales (K Units) and Growth Rate Figure Middle East and Africa Rotavirus Sales (K Units) and Growth Rate Table Middle East and Africa Cholera Sales (K Units) and Growth Rate Figure Middle East and Africa Cholera Sales (K Units) and Growth Rate Table GlaxoSmithKline Plc. Profiles Table GlaxoSmithKline Plc. Product Information Table GlaxoSmithKline Plc. Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019 Table GlaxoSmithKline Plc. Oral Vaccines Sales Change 2014-2019 Table GlaxoSmithKline Plc. Oral Vaccines Market Status Change 2014-2019 Table PaxVax Corporation Profiles Table PaxVax Corporation Product Information Table PaxVax Corporation Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019 Table PaxVax Corporation Oral Vaccines Sales Change 2014-2019 Table PaxVax Corporation Oral Vaccines Market Status Change 2014-2019 Table Pfizer Inc Profiles Table Pfizer Inc Product Information Table Pfizer Inc Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019 Table Pfizer Inc Oral Vaccines Sales Change 2014-2019 Table Pfizer Inc Oral Vaccines Market Status Change 2014-2019 Table Merial, Inc. Profiles Table Merial, Inc. Product Information Table Merial, Inc. Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019 Table Merial, Inc. Oral Vaccines Sales Change 2014-2019 Table Merial, Inc. Oral Vaccines Market Status Change 2014-2019 Table Merck Sharp & Dohme Corp Profiles Table Merck Sharp & Dohme Corp Product Information Table Merck Sharp & Dohme Corp Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019 Table Merck Sharp & Dohme Corp Oral Vaccines Sales Change 2014-2019 Table Merck Sharp & Dohme Corp Oral Vaccines Market Status Change 2014-2019 Table VALNEVA Canada Inc. Profiles Table VALNEVA Canada Inc. Product Information Table VALNEVA Canada Inc. Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019 Table VALNEVA Canada Inc. Oral Vaccines Sales Change 2014-2019 Table VALNEVA Canada Inc. Oral Vaccines Market Status Change 2014-2019 Table QUíMICA SUIZA S.A Profiles
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
